Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Currently, aspects related to the effects of anticancer treatments and the quality of life of patients and their needs are still poorly documented at the Rafael Institute. Thus this study will meet a dual objective: (1) the establishment of a registry to collect data on the safety and effectiveness of innovative and expensive anticancer drugs when administered in real life and (2) a measurement quantitative quality of life of patients treated with these drugs.
Eligibility Criteria
Inclusion Criteria: * Age equal to or greater than 18 years (adult) * Patients treated with an anticancer drug included in the list of innovative/expensive therapies (protocol appendix) * Patients benefiting from non-pharmacological treatment at the Rafael Institute * Who understands the French language Exclusion Criteria: * \< 18 years old * Patient deprived of liberty, under guardianship or unable to give consent